Dr. Val Hansen

Internal Medicine
Joshua Oaks MD PLLC
520 Medical Dr Ste 300, 
Bountiful, UT 
Joshua Oaks MD PLLC
520 Medical Dr Ste 300, 
Bountiful, UT 

Overview

Val Hansen is a primary care provider, practicing in Internal Medicine in Bountiful, Utah.

His clinical expertise encompasses Cerebellar Degeneration, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Hemorrhoidectomy, and Endoscopy.

He is actively involved in clinical research, participating in 7 clinical trials.

Specialties

Internal Medicine

Licenses

Internal Medicine in UT

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
BridgeSpan
  • EPO
  • HMO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Deseret Mutual Benefit Administrators
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Regence
  • EPO
  • PPO
SelectHealth
  • HMO
  • POS
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
University of Utah Health
  • EPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Joshua Oaks MD PLLC
520 Medical Dr Ste 300, Bountiful, UT 84010

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: January 21, 2026
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 1b Randomized, Double-Blind, Placebo-Controlled, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy of SER-262 in Adults With Primary Clostridium Difficile Infection (CDI) to Prevent Recurrence
A Phase 1b Randomized, Double-Blind, Placebo-Controlled, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy of SER-262 in Adults With Primary Clostridium Difficile Infection (CDI) to Prevent Recurrence
Enrollment Status: Completed
Publish Date: February 06, 2023
Intervention Type: Drug
Study Phase: Phase 1
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 305)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Enrollment Status: Terminated
Publish Date: April 29, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
View 6 Less Clinical Trials
Similar Doctors
Expertise in
8
conditions
Dr. Scott Stevens
Internal Medicine
Expertise in
8
conditions
Dr. Scott Stevens
Internal Medicine

Imed Physicians

5121 S Cottonwood St, 
Murray, UT 
 (15.8 miles away)
801-507-3380
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Scott Stevens is a primary care provider, practicing in Internal Medicine in Murray, Utah. Dr. Stevens is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Deep Vein Thrombosis, Venous Thromboembolism (VTE), Mesenteric Venous Thrombosis, Thrombectomy, and Liver Transplant. Dr. Stevens is board certified in American Board Of Internal Medicine. Dr. Stevens is currently accepting new patients.

Expertise in
5
conditions
Dr. Scott Woller
Internal Medicine
Expertise in
5
conditions
Dr. Scott Woller
Internal Medicine

Imed Physicians

5121 S Cottonwood St, 
Murray, UT 
 (15.8 miles away)
801-507-3380
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Scott Woller is a primary care provider, practicing in Internal Medicine in Murray, Utah. Dr. Woller is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Venous Thromboembolism (VTE), Mesenteric Venous Thrombosis, Deep Vein Thrombosis, Thrombectomy, and Knee Replacement. Dr. Woller is board certified in American Board Of Internal Medicine. Dr. Woller is currently accepting new patients.

Expertise in
3
conditions
Dr. Andrew Chang
Internal Medicine
Expertise in
3
conditions
Dr. Andrew Chang
Internal Medicine

Gen. Med. Division - Sugarhouse

1280 E Stringham Ave, 
Salt Lake City, UT 
 (11.5 miles away)
801-581-7818
Experience:
18+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Andrew Chang is an Internal Medicine provider practicing medicine in Salt Lake City, Utah. He has been practicing medicine for over 18 years. Dr. Chang is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Diabetic Macular Edema (DME), Vitrectomy, and Cataract Removal. Dr. Chang is board certified in American Board Of Internal Medicine. Dr. Chang is currently accepting new patients.

Frequently Asked Questions about Dr. Val Hansen

How do I make an appointment with Dr. Val Hansen?

You can book an appointment with Dr. Val Hansen by calling their office at 801-292-1422. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Val Hansen a top-rated expert for Cerebellar Degeneration?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Val Hansen is classified as an Experienced expert for Cerebellar Degeneration, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Val Hansen specialize in?

While Dr. Val Hansen is a Internal Medicine, they have specific expertise in Cerebellar Degeneration, Type 2 Diabetes (T2D), and Hemorrhoidectomy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Val Hansen accept my insurance?

Dr. Val Hansen accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 801-292-1422 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hansen's expertise for a condition
ConditionClose
        View All 39 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile